Deepak Nitrite Limited
FIRST QUARTER RESULTS
Q1 FY 2013
DEEPAK NITRITE LIMITED has declared decent Results for the first Quarter ending
June,2012.
Net Sales for
Q1 FY 13 stands at Rs.206.57 Cr; down by -7.59% from Q4 FY 12 (Rs.223.53Cr);
and up by 25.48% from Q1 FY 12 (Rs.164.62 Cr.)Sales have registered decent
increase YoY.
Total Expenditure for Q1 FY 13 stands at Rs.196.84 Cr; down by
-7.31% from Q4 FY 12 (Rs.212.36Cr);
and up by 23.91% from Q1 FY 12 (Rs.158.86 Cr).
Profit before Interest, Dep. & Taxes for Q1 FY
13 stands at Rs.9.73 Cr; down by -12.89% from Q4 FY 12 (Rs.11.16 Cr); and up by
68.71% from Q1 FY 12 (Rs.5.76 Cr).
Net Profit for Q1 FY 13 stands at Rs.12.1Cr; up by 26.34% from Q4 FY 12 (Rs.9.58 Cr); and
up by 98.51% from Q1 FY 12 (Rs.6.09 Cr).
Diluted EPS (On a Face Value of Rs.10) for Q1 FY 13
stands at Rs.11.56; at Rs.9.15 for Q4 FY 12; and at Rs.5.82 for Q1 FY 12.
Paid-up Equity : Rs.10.45 Cr; Public Shareholding : 44.07%;
52 week high/low price : Rs.199.00/136.30;Current MP :
Rs.163;
ABOUT THE COMPANY
Deepak Nitrite is a leading manufacturer of organic,
inorganic, fine and specialty chemicals and a world leader in 2,4 and 2,6
Xylidine. Working with its partners, customers, it seeks to find better ways to
meet market demands, using innovative processes and methods.
Deepak Nitrite is the preferred business partner of
chemical majors worldwide in Pharma, Rubber, Colourants and Imaging chemicals.
Headquartered at Pune, It is a multi-division and multi-product company that
has manufacturing facilities at Nandesari, in Gujarat and at Pune, Roha and
Taloja in Maharashtra and Hyderabad in Andhra Pradesh, all of them complying
with ISO 9001:2000 standards.
The company says : “The Company is now at a landmark
inflection point as it climbs up the value chain to offer not only bulk
chemicals and intermediates but also high value ready to use chemical products
and also offer relevant chemical solutions to industries. A feat made possible
by the expected completion of its greenfield project at Dahej which will manufacture
Fine & Speciality Performance Chemical (Optical Brightening Agents - OBA).
This would be the most integrated plant in the world. The ability to manufacture OBA brightens the
Company’s growth potential, ushers it into a new promising world of product
application markets and opens new vistas of opportunities as it climbs up the
value chain from chemicals to solution provider.”
ANNUAL REPORT 2011-12
Operational
highlights
Increase in turnover by
nearly 18% in FY12 as compared to FY11
Turnover crossed the Rs.775 crores mark
Dividend rate maintained at
60%
Greenfield
state-of-the-art project at Dahej under implementation.
The Company’s new greenfield plant at Dahej will be manufacturing Optical
Brightening Agents (OBA), a Fine & Speciality chemical. The Company’s new
state-of-the-art plant at Dahej will be one of the largest.
ECB loan availed USD 45
million
Fuel Additives contributed
to about Rs.100 crores for FY12 as against Rs.63 crores for FY11
Brownfield expansion at Nandesari
is underway
Turnover from U.S. contributed
to about Rs.60 crores for FY12, 34% growth compared to FY11.
INTEGRATION ADVANTAGE : DASDA
is manufactured at the Company’s Hyderabad facility while PNT is manufactured
at the Nandesari plant. Deepak Nitrite will be the most integrated player in
the world.
RESULTS TABLE
|
deepak
nitrite
|
30-Jun-12
|
QoQ %
dif
|
31-Mar-12
|
YoY %
Dif
|
30-Jun-11
|
31-Dec-11
|
30-Sep-11
|
|
Net Sales
|
20656.7
|
-7.59
|
22352.78
|
25.48
|
16462.46
|
20889.33
|
17945.72
|
|
Total Expenditure
|
19684.12
|
-7.31
|
21236.31
|
23.91
|
15885.99
|
20415.52
|
17746.91
|
|
Profit before Interest, Dep. & Taxes
|
972.58
|
-12.89
|
1116.47
|
68.71
|
576.47
|
473.81
|
198.81
|
|
Net Profit
|
1209.88
|
26.34
|
957.62
|
98.51
|
609.47
|
460.29
|
280.9
|
|
Diluted EPS
|
11.56
|
26.34
|
9.15
|
98.63
|
5.82
|
4.4
|
2.68
|
|
Net Sales
|
20656.7
|
-7.59
|
22352.78
|
25.48
|
16462.46
|
20889.33
|
17945.72
|
|
Cost of materials consumed
|
16714.29
|
-0.3
|
16764.23
|
56.55
|
10676.44
|
13275.43
|
12171.28
|
|
Purchases of SIT
|
728.86
|
-40.23
|
1219.52
|
-19.93
|
910.32
|
1289.06
|
930.17
|
|
Employee benefits
|
1473.69
|
11.4
|
1322.93
|
17.32
|
1256.08
|
1237.95
|
1240.6
|
|
Depreciation
|
463.34
|
0.8
|
459.64
|
6.04
|
436.94
|
442.74
|
439.26
|
|
Other expenses
|
1827.51
|
16.96
|
1562.51
|
-41.48
|
3122.96
|
3779.08
|
3621.75
|
|
Total expenses
|
19684.12
|
-7.31
|
21236.31
|
23.91
|
15885.99
|
20415.52
|
17746.91
|
|
Profit
before tax
|
1791.09
|
33.99
|
1336.72
|
116.34
|
827.92
|
612.4
|
381.55
|
|
Tax Expenses
|
581.21
|
53.31
|
379.1
|
166.06
|
218.45
|
152.11
|
100.65
|
|
Net Profit
|
1209.88
|
26.34
|
957.62
|
98.51
|
609.47
|
460.29
|
280.9
|
|
Face Value(Rs )
|
10
|
10
|
0
|
10
|
10
|
10
|
|
|
Paid-up Equity
|
1045.38
|
0
|
1045.38
|
0
|
1045.38
|
1045.38
|
1045.38
|
|
Diluted EPS
|
11.56
|
26.34
|
9.15
|
98.63
|
5.82
|
4.4
|
2.68
|
|
Public Shareholding (%)
|
44.07
|
0
|
44.07
|
0
|
44.07
|
44.07
|
44.07
|
*
* * E
N D *
* *
No comments:
Post a Comment